What is Morgan Stanley's price target for PATH?

Morgan Stanley's latest stated price target for UiPath Inc. (PATH) is $15, from its action on Sep 7, 2022.

What is Morgan Stanley's rating on PATH?

Morgan Stanley rates PATH Equal-Weight, a neutral rating, as of Sep 7, 2022.

When did Morgan Stanley last change its view on PATH?

On Sep 7, 2022, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $32 to $15.

Morgan Stanley PATH price target and rating history

Morgan Stanley rates UiPath Inc. (PATH) Equal-Weight with a $15 price target, as of its latest action on Sep 7, 2022. It has published 3 rating actions on PATH since September 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a PATH price target in the last 12 months, the median target is $15.

Current rating: Equal-Weight
Price target: $15
Median target, all firms: $15
Actions on PATH: 3

Morgan Stanley price target on PATH

Morgan Stanley price target on PATH, each point a stated target, September 2021 to September 2022.

Every Morgan Stanley rating on PATH

Sep 7, 2022
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $32 to $15
Dec 3, 2021
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $74
Sep 8, 2021
ReiterateMorgan Stanley raises its price target to $74 from $72, keeps Equal-Weight

How other firms rate PATH

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
DA Davidson	Underperform	$10	Sep 28, 2026
BMO Capital Markets	Market Perform	$15	Sep 24, 2026
Canaccord Genuity	Hold	$17	Sep 4, 2026
Needham	Buy	$15	Mar 12, 2026

Questions about Morgan Stanley and PATH

What is Morgan Stanley's price target for PATH?: Morgan Stanley's latest stated price target for UiPath Inc. (PATH) is $15, from its action on Sep 7, 2022.
What is Morgan Stanley's rating on PATH?: Morgan Stanley rates PATH Equal-Weight, a neutral rating, as of Sep 7, 2022.
When did Morgan Stanley last change its view on PATH?: On Sep 7, 2022, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $32 to $15.
How does Morgan Stanley's PATH target compare with other analysts?: Across 4 firms with a PATH price target in the last 12 months, the median target is $15.

More PATH rating histories

All Morgan Stanley ratings PATH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.